⌘K

Home/Filings/4/0001048477-25-000039

4//SEC Filing

Burkhart Erin 4

Accession 0001048477-25-000039

CIK 0001048477other

View on SEC.gov Company Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 7:53 PM ET

Size

8.2 KB

Accession

0001048477-25-000039

Insider Transaction Report

Form 4

Period: 2025-03-14

BIOMARIN PHARMACEUTICAL INCBMRN

GVP, Chief Accounting Officer

Transactions

Award
Stock Option (Right to Buy Common Stock)
2025-03-17+9,230→ 9,230 total
Exercise: $71.55From: 2026-03-17Exp: 2035-03-16→ Common Stock (9,230 underlying)
Tax Payment
Common Stock
2025-03-14$69.44/sh−823$57,149→ 12,282 total
Award
Common Stock
2025-03-17+5,970→ 18,252 total

Footnotes (2)

[F1]Restricted stock units granted March 17, 2025. Price not applicable.
[F2]Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.

Documents

1 file

4
wk-form4_1742341974.xmlPrimary
FORM 4

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1

filerCIK 0001927648

Filing Metadata

Form type: 4
Filed: Mar 17, 8:00 PM ET
Accepted: Mar 18, 7:53 PM ET
Size: 8.2 KB

View on SEC.gov